Outcome of patients with melanoma and histologically negative sentinel lymph nodes: One institution's experience

Oncology

Volumn 73, Issue 5-6, 2008, Pages 401-406

  De Giorgi, Vincenzo ^a   Leporatti, Genny ^a   Massi, Daniela ^a   Lo Russo, Giulia ^a   Sestini, Serena ^a   Dini, Mario ^a   Lotti, Torello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Disease progression; Lymph node metastasis; Melanoma

Indexed keywords

ALBUMIN TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROMETASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODES; MALE; MELANOMA; MIDDLE AGED; RECURRENCE; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 45549087532     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000136795     Document Type: Article

References (20)

1. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-3634.
2. Balch CM, Buzaid AC, Soong SJ, et al: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-3648.
3. Thompson JF, Scolyer RA, Kefford RF: Cutaneous melanoma. Lancet 2005;365:687-701.
4. Thomas JM: Caution with sentinel node biopsy in melanoma. Br J Surg 2006;93:129-130.
5. Morton DL, Thompson JF, Cochran AJ, et al: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307-1317.
6. Morton DL, Thompson JF, Cochran AJ, et al: Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in clinical stage 1 melanoma. J Clin Oncol 2005;23(suppl):S710.
7. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
8. Thomas JM: Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial. J Clin Oncol 2005;23:9443-9444.
9. Gershenwald JE, Thomson W, Mansfield PF, et al: Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-983.
10. Starz H, Siedlecki K, Balda BR: Sentinel lymphonodectomy and S-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004; 11(suppl 3):162S-168S.
11. Carlson GW, Murray DR, Lyles RH, et al: The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003;10:575-581.
12. Spanknebel K, Coit DG, Bieligk SC, et al: Characterisation of micrometastastic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 2005;29:305-317.
13. Roka F, Kittler H, Cauzig P, et al: Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. Br J Cancer 2005;92:662-666.
14. Vuylsteke RJCLM, Van Leeuwen PAM, Statius Muller MG, et al: Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long term follow-up results. J Clin Oncol 2003;21:1057-1065.
15. Gadd MA, Cosimi BA, Yu B, et al: Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 1999;134:381-387.
16. Nowecki ZI, Rutkowski P, Guttmejer AN, Ruka W: Sentinel lymph node biopsy in melanoma patients with clinical negative regional lymph nodes - one institution's experience. Mel Res 2003;13:35-43.
17. Nieweg OE, Estourgie SH: What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 2004;11(suppl):169S-173S.
18. Leiter U, Friedegund M, Schittek M, Garbe C: The natural course of cutaneous melanoma. J Surg Oncol 2004;86:172-178.
19. Meier F, Will S, Ellwanger U, et al: Metastatic pathways and time courses in the olderly progression of cutaneous melanoma. Br J Dermatol 2002;147:62-70.
20. De Giorgi V, Leporatti G, Massi D, et al: Sentinel lymph nodes in melanoma patients: evaluating the evidence. Oncology 2006;71:460-462.